TCI Wealth Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-421
Closed -$7.33K 1485
2023
Q1
$7.33K Sell
421
-252
-37% -$3.59K ﹤0.01% 1274
2022
Q4
$6.22K Buy
+673
New +$6.27K ﹤0.01% 1383
2022
Q3
Sell
-393
Closed -$3K 2478
2022
Q2
$3K Buy
+393
New +$3.75K ﹤0.01% 1846
2022
Q1
Sell
-125
Closed -$4K 2373
2021
Q4
$4K Sell
125
-253
-67% -$9.91K ﹤0.01% 1857
2021
Q3
$18K Buy
378
+167
+79% +$7.73K ﹤0.01% 732
2021
Q2
$10K Sell
211
-63
-23% -$2.79K ﹤0.01% 971
2021
Q1
$13K Buy
274
+122
+80% +$6.35K 0.01% 720
2020
Q4
$8K Hold
152
﹤0.01% 716
2020
Q3
$6K Hold
152
﹤0.01% 721
2020
Q2
$5K Hold
152
﹤0.01% 752
2020
Q1
$4K Buy
152
+82
+117% +$2.46K ﹤0.01% 779
2019
Q4
$2K Sell
70
-45
-39% -$1.07K ﹤0.01% 1172
2019
Q3
$2K Buy
115
+45
+64% +$1.06K ﹤0.01% 1107
2019
Q2
$2K Buy
70
+17
+32% +$373 ﹤0.01% 1035
2019
Q1
$1K Buy
+53
New +$921 ﹤0.01% 1265
2016
Q4
Sell
-59
Closed 1422
2016
Q3
$0 Hold
59
﹤0.01% 1387
2016
Q2
$0 Buy
+59
New +$473 ﹤0.01% 1351

Other funds holding NEO

TCI Wealth Advisors's NEO Position: Q2 2023 in Review

TCI Wealth Advisors sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 421 shares — an estimated $7.33K sold.

TCI Wealth Advisors first reported a position in NEO in Q2 2016 and held it in 17 quarters. The position peaked at $18K in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • TCI Wealth Advisors reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 421 NeoGenomics shares in Q2 2023, an estimated $7.33K.
  • TCI Wealth Advisors first reported a position in NeoGenomics in Q2 2016 and held it in 17 quarters.
  • TCI Wealth Advisors's NeoGenomics position peaked at $18K in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.